| Thomas H Hostetter, MD | |
|
11100 Euclid Avenue, Cleveland, OH 44106 | |
| (216) 844-8500 | |
| Not Available |
| Full Name | Thomas H Hostetter |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 51 Years |
| Location | 11100 Euclid Avenue, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750488581 | NPI | - | NPPES |
| 0053895 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 239402 (New York) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 35-097996 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of North Carolina Hospital | Chapel hill, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, today announced treatment of the final patient in the first patient cohort in its Phase 1/2 clinical trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).
Journal of the American Heart Association reports that exposure to air pollution can contribute to the development of cardiovascular diseases.
There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells.
California cut program budgets aimed at providing care for the poor while in Wyoming, the programs themselves are forced to close their doors because of a funding shortfall. In Kansas, lawmakers are examining — ahead of final consideration of health care reform in Congress — how they can shield themselves from health care mandates to carry insurance.
› Verified 6 days ago
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, today announced treatment of the final patient in the first patient cohort in its Phase 1/2 clinical trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).
Journal of the American Heart Association reports that exposure to air pollution can contribute to the development of cardiovascular diseases.
There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells.
California cut program budgets aimed at providing care for the poor while in Wyoming, the programs themselves are forced to close their doors because of a funding shortfall. In Kansas, lawmakers are examining — ahead of final consideration of health care reform in Congress — how they can shield themselves from health care mandates to carry insurance.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas H Hostetter, MD 24701 Euclid Avenue, 3rd Floor, Euclid, OH 44117 Ph: () - | Thomas H Hostetter, MD 11100 Euclid Avenue, Cleveland, OH 44106 Ph: (216) 844-8500 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, today announced treatment of the final patient in the first patient cohort in its Phase 1/2 clinical trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).
Journal of the American Heart Association reports that exposure to air pollution can contribute to the development of cardiovascular diseases.
There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells.
California cut program budgets aimed at providing care for the poor while in Wyoming, the programs themselves are forced to close their doors because of a funding shortfall. In Kansas, lawmakers are examining — ahead of final consideration of health care reform in Congress — how they can shield themselves from health care mandates to carry insurance.
› Verified 6 days ago
Amir Razavi, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Dr. Francois Fadell, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18200 Lorain Ave, Moll Cancer Center At Fairview- Respiratory Institute, Cleveland, OH 44111 Phone: 216-444-6503 | |
Sana Hasan, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 330-721-5700 | |
Catherine Frakes Vozzo, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-4444 Fax: 216-445-6290 | |
Tarek Ashour, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Q7, Cleveland, OH 44195 Phone: 216-444-5040 | |
Mrs. Efewongbe Benedicta Oleghe, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2351 E 22nd Street, St Vincent's Charity Medical Center, Cleveland, OH 44115 Phone: 216-363-2725 | |
Dr. Toufik Z. Madhun, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave Dept Of, Cleveland, OH 44106 Phone: 216-844-1000 |